ATC code D05

ATC codes
D Dermatologicals
	D01 Antifungals for dermatological use
	D02 Emollients and protectives
	D03 Preparations for treatment of wounds and ulcers
	D04 Antipruritics, including antihistamines, anesthetics, etc.
	D05 Antipsoriatics
	D06 Antibiotics and chemotherapeutics for dermatological use
	D07 Corticosteroids, dermatological preparations
	D08 Antiseptics and disinfectants
	D09 Medicated dressings
	D10 Anti-acne preparations
	D11 Other dermatological preparations
ATCvet only
	QD51 Products for the treatment of claws and hoofs
A B C D G H QI J L M N P R S V ; (Hover over links to see titles) ;

ATC code D05 Antipsoriatics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1]^[2] Subgroup D05 is part of the anatomical group D Dermatologicals.^[3]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QD05.^[4]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

In ATCvet, this subgroup is named "QD05 Drugs for keratoseborrheic disorders".

D05A Antipsoriatics for topical use[edit]

In ATCvet, this subgroup is named "QD05A Drugs for keratoseborrheic disorders, topical use".

D05AA Tars[edit]

D05AC Antracen derivatives[edit]

D05AC01 Dithranol

D05AC51 Dithranol, combinations

D05AD Psoralens for topical use[edit]

D05AD01 Trioxysalen

D05AD02 Methoxsalen

D05AX Other antipsoriatics for topical use[edit]

In ATCvet, this subgroup is named "QD05AX Other drugs for keratoseborrheic disorders for topical use".

D05AX01 Fumaric acid

D05AX02 Calcipotriol

D05AX03 Calcitriol

D05AX04 Tacalcitol

D05AX05 Tazarotene

D05AX52 Calcipotriol, combinations

D05B Antipsoriatics for systemic use[edit]

In ATCvet, this subgroup is named "QD05B Drugs for keratoseborrheic disorders, systemic use".

D05BA Psoralens for systemic use[edit]

D05BA01 Trioxysalen

D05BA02 Methoxsalen

D05BA03 Bergapten

D05BB Retinoids for treatment of psoriasis[edit]

D05BB01 Etretinate

D05BB02 Acitretin

D05BX Other antipsoriatics for systemic use[edit]

In ATCvet, this subgroup is named "QD05BX Other drugs for keratoseborrheic disorders for systemic use".

D05BX51 Fumaric acid derivatives, combinations

References[edit]

↑ ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). National Institutes of Health.
↑ ATC-Klassifikation mit definierten Tagesdosen DDD(link). German Institute for Medical Documentation and Information.
↑ ATC/DDD Index 2022
code D05(link). WHO Collaborating Centre for Drug Statistics Methodology.
↑ ATCvet Index 2022
code QD05(link). WHO Collaborating Centre for Drug Statistics Methodology.

Navigation-> Medicine - Wellness - Encyclopedia - Health topics - Diseases - Drugs - Gray's Anatomy - W8MD diet - Ketogenic diet - Recipes

Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Translate page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian

[1] ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). National Institutes of Health.

[2] ATC-Klassifikation mit definierten Tagesdosen DDD(link). German Institute for Medical Documentation and Information.

[3] ATC/DDD Index 2022
code D05(link). WHO Collaborating Centre for Drug Statistics Methodology.

[4] ATCvet Index 2022
code QD05(link). WHO Collaborating Centre for Drug Statistics Methodology.

[1]

[2]

[3]

[4]